Matches in SemOpenAlex for { <https://semopenalex.org/work/W4315705521> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- W4315705521 endingPage "e354" @default.
- W4315705521 startingPage "e354" @default.
- W4315705521 abstract "Objectives: Blood pressure and volume control is required in patients undergoning peritoneal dialysis (PD). Residual renal function play an important role in PD vintage and mortality, and also dependent on blood pressure and volume control. Sacubitril-valsartan, and angiotensin receptor-neprilysin inhibitor (ARNI), has been approved to use for blood pressure control in Japan. However, the antihypertensive effect of sacubitril-valsartan in PD patients is not well known. Thus, the present study was designed to determine the efficacy and safety of ARNI in hypertensive patients undergoing PD. Methods: Hypertensive end-stage kindey disease (ESKD) patients and systolic blood pressure of more than 135 mmHg despite of other hypertensive drugs was administered sacubitril-valsartan. Clinical parameters such as home blood pressure, body weight, brain natriuretic peptide and urine volume was monitored. Body fluid composition was analyzed by bioimpedance method. Results: Eleven PD patients received sacubitril-valsaltan at a dose between 100–400 mg. Blood pressure decreased in seven patients. Then, those who responded (Res group, n = 7) to sacubitril-valsartan was compared to those did not responded (Non-Res group, n = 4). Significantl decrease in blood pressure was observed in Res group by 16.9 ± 10.2mmHg, while increase was observed in Non-Res group by 10.8 ± 7.8mmHg. Plasma BNP tended to decrease in both groups but did not reach to a level of significance. Body weight, urine volume, extracelullar water / total body water did not change in either group. Conclusions: Antihypertensive effect of sacubitril-valsartan was observed in limited patients of ESKD patients undergoing PD. However, BNP was reduced in most patients treated with sacubitril-valsartan with no adversed effects. Although ARNI could be beneficial antihypertensive drugs for cirtain hypertensive ESKD patients undergoing PD, further study is requied." @default.
- W4315705521 created "2023-01-12" @default.
- W4315705521 creator A5018887470 @default.
- W4315705521 creator A5021372077 @default.
- W4315705521 creator A5030303712 @default.
- W4315705521 creator A5053476006 @default.
- W4315705521 creator A5059179367 @default.
- W4315705521 creator A5061252963 @default.
- W4315705521 creator A5061470467 @default.
- W4315705521 creator A5065298452 @default.
- W4315705521 creator A5074031156 @default.
- W4315705521 creator A5075081663 @default.
- W4315705521 creator A5083330793 @default.
- W4315705521 creator A5083655563 @default.
- W4315705521 creator A5085235219 @default.
- W4315705521 creator A5087797526 @default.
- W4315705521 date "2023-01-01" @default.
- W4315705521 modified "2023-10-02" @default.
- W4315705521 title "PS-BPR03-7: ANTIHYPERTENSIVE EFFECT OF ANGIONTENSIN RECEPTOR-NEPRILYSIN INHIBITION IN PERITONEAL DIALYSIS PATIENTS" @default.
- W4315705521 doi "https://doi.org/10.1097/01.hjh.0000916368.57876.c7" @default.
- W4315705521 hasPublicationYear "2023" @default.
- W4315705521 type Work @default.
- W4315705521 citedByCount "0" @default.
- W4315705521 crossrefType "journal-article" @default.
- W4315705521 hasAuthorship W4315705521A5018887470 @default.
- W4315705521 hasAuthorship W4315705521A5021372077 @default.
- W4315705521 hasAuthorship W4315705521A5030303712 @default.
- W4315705521 hasAuthorship W4315705521A5053476006 @default.
- W4315705521 hasAuthorship W4315705521A5059179367 @default.
- W4315705521 hasAuthorship W4315705521A5061252963 @default.
- W4315705521 hasAuthorship W4315705521A5061470467 @default.
- W4315705521 hasAuthorship W4315705521A5065298452 @default.
- W4315705521 hasAuthorship W4315705521A5074031156 @default.
- W4315705521 hasAuthorship W4315705521A5075081663 @default.
- W4315705521 hasAuthorship W4315705521A5083330793 @default.
- W4315705521 hasAuthorship W4315705521A5083655563 @default.
- W4315705521 hasAuthorship W4315705521A5085235219 @default.
- W4315705521 hasAuthorship W4315705521A5087797526 @default.
- W4315705521 hasBestOaLocation W43157055211 @default.
- W4315705521 hasConcept C126322002 @default.
- W4315705521 hasConcept C126894567 @default.
- W4315705521 hasConcept C159641895 @default.
- W4315705521 hasConcept C164705383 @default.
- W4315705521 hasConcept C2775999527 @default.
- W4315705521 hasConcept C2776754050 @default.
- W4315705521 hasConcept C2777387769 @default.
- W4315705521 hasConcept C2779056158 @default.
- W4315705521 hasConcept C71924100 @default.
- W4315705521 hasConcept C84393581 @default.
- W4315705521 hasConceptScore W4315705521C126322002 @default.
- W4315705521 hasConceptScore W4315705521C126894567 @default.
- W4315705521 hasConceptScore W4315705521C159641895 @default.
- W4315705521 hasConceptScore W4315705521C164705383 @default.
- W4315705521 hasConceptScore W4315705521C2775999527 @default.
- W4315705521 hasConceptScore W4315705521C2776754050 @default.
- W4315705521 hasConceptScore W4315705521C2777387769 @default.
- W4315705521 hasConceptScore W4315705521C2779056158 @default.
- W4315705521 hasConceptScore W4315705521C71924100 @default.
- W4315705521 hasConceptScore W4315705521C84393581 @default.
- W4315705521 hasIssue "Suppl 1" @default.
- W4315705521 hasLocation W43157055211 @default.
- W4315705521 hasLocation W43157055212 @default.
- W4315705521 hasOpenAccess W4315705521 @default.
- W4315705521 hasPrimaryLocation W43157055211 @default.
- W4315705521 hasRelatedWork W2125399797 @default.
- W4315705521 hasRelatedWork W2776335933 @default.
- W4315705521 hasRelatedWork W2904992990 @default.
- W4315705521 hasRelatedWork W2914028752 @default.
- W4315705521 hasRelatedWork W2997619002 @default.
- W4315705521 hasRelatedWork W3102803564 @default.
- W4315705521 hasRelatedWork W3152772598 @default.
- W4315705521 hasRelatedWork W3188325112 @default.
- W4315705521 hasRelatedWork W3195938057 @default.
- W4315705521 hasRelatedWork W4235888460 @default.
- W4315705521 hasVolume "41" @default.
- W4315705521 isParatext "false" @default.
- W4315705521 isRetracted "false" @default.
- W4315705521 workType "article" @default.